Frontierby eninvs

Language: EN · RU

← Region

BRF S.A. (BRFS) USD

BRF S.A. is a Brazilian food company that processes and sells poultry, pork, and other meat products, as well as processed foods, to domestic and international markets.

At a glance: strengths & risks
Revenue growing (+14% y/y, Q2 2026)Profit falling (-19% y/y, Q2 2026)

Sector: Food and agro

Geography: Brazil

COMM_BRFS

No intraday sparkline from the default exchange feed; Yahoo or day change may still appear below when available.

No price chart.

Key metrics

Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.

Market

Price
Market cap
2.7 bn USD

Growth

Δ revenue y/y
14.1%
Δ EBITDA y/y
10.3%

Multiples

P/E (LTM)
5.8x
P/B (FY)
1.0x
P/E (ann.)
6.4x
EV/EBITDA (LTM)
3.0x
EV/EBITDA (ann.)
2.9x

Cash return

Dividend yield
FCF yield (LTM)
42.4%

Value creation

fundamental value/yr, % of market cap
Value created / year

Liquidity

Daily turnover

Shares: unknown

Financial results

Monetary columns are in B USD, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.

DatePeriodStatusRevenueB USDOperating profitB USDD&AB USDEBITDAB USDNet profitB USDOperating CFB USDCapex + M&AB USDAssetsB USDEquityB USDROE (annualized)Net debtB USDSource
2026-06-30Q2 2026 (3M)PARTIAL3.1
y/y 14.1%
0.3
y/y 5.2%
0.2
y/y 19.5%
0.5
y/y 10.3%
0.1
y/y -18.6%
0.50.013.3
y/y 15.5%
3.0
y/y -7.3%
14.1%2.9Evidence
2026-03-31Q1 2026 (3M)PARTIAL3.1
y/y 10.7%
0.3
y/y -15.1%
0.2
y/y 21.6%
0.5
y/y -3.8%
0.1
y/y -49.1%
0.4-0.213.2
y/y 17.8%
3.1
y/y -0.8%
14.8%2.9Evidence
2025-12-31Q4 2025 (3M)PARTIAL3.3
y/y 68.6%
0.3
y/y 40.6%
0.2
y/y 74.9%
0.5
y/y 51.8%
0.1
y/y 24.2%
0.4-0.212.5
y/y 22.9%
2.7
y/y 2.8%
21.5%2.7Evidence
2025-09-30Q3 2025 (3M)PARTIAL3.0
y/y 13.1%
0.3
y/y -14.0%
0.2
y/y 11.0%
0.5
y/y -6.5%
0.1
y/y -25.6%
0.4-0.211.9
y/y 13.8%
2.8
y/y -7.3%
6.4%1.6Evidence
2025-06-30Q2 2025 (3M)PARTIAL2.8
y/y 3.6%
0.3
y/y -6.6%
0.2
y/y 2.7%
0.4
y/y -3.5%
0.1
y/y -32.4%
0.5-0.211.5
y/y 4.7%
3.2
y/y 8.4%
16.6%1.0Evidence
2025-03-31Q1 2025 (3M)PARTIAL2.8
y/y 5.6%
0.3
y/y 37.0%
0.1
y/y -9.9%
0.5
y/y 18.1%
0.2
y/y 81.7%
0.6-0.111.2
y/y 0.0%
3.1
y/y -1.4%
29.3%1.2Evidence
2024-12-31Q4 2024 (3M)PARTIAL2.0
y/y -36.9%
0.2
y/y 6.9%
0.1
y/y -45.7%
0.3
y/y -18.8%
0.1
y/y -42.1%
0.3-0.110.1
y/y -14.3%
2.7
y/y -17.4%
20.8%1.4Evidence
2024-09-30Q3 2024 (3M)PARTIAL2.7
y/y -1.5%
0.3
y/y 290.2%
0.1
y/y -5.0%
0.5
y/y 102.4%
0.2
y/y
0.7-0.110.5
y/y -10.6%
3.1
y/y 3.5%
8.7%1.5Evidence
2024-06-30Q2 2024 (3M)PARTIAL2.7
y/y 3.0%
0.3
y/y
0.2
y/y -6.6%
0.5
y/y 415.9%
0.2
y/y
0.4-0.111.0
y/y -4.2%
3.0
y/y 47.3%
25.4%1.8Evidence
2024-03-31Q1 2024 (3M)PARTIAL2.6
y/y -1.1%
0.2
y/y
0.2
y/y 5.4%
0.4
y/y 238.5%
0.1
y/y
0.4-0.111.2
y/y -3.4%
3.1
y/y 44.0%
14.6%1.9Evidence
2023-12-31Q4 2023 (3M)PARTIAL3.1
y/y
0.2
y/y
0.2
y/y
0.4
y/y
0.2
y/y
0.4-0.111.8
y/y
3.2
y/y
-12.5%2.1Evidence
2023-09-30Q3 2023 (3M)PARTIAL2.7
y/y
0.1
y/y
0.2
y/y
0.2
y/y
0.2
y/y
0.2-0.111.7
y/y
3.0
y/y
-2.8%2.2Evidence
2023-06-30Q2 2023 (3M)PARTIAL2.6
y/y
-0.1
y/y
0.2
y/y
0.1
y/y
-0.1
y/y
0.2-0.111.5
y/y
2.0
y/y
-53.8%3.4Evidence
2023-03-31Q1 2023 (3M)PARTIAL2.6
y/y
0.0
y/y
0.2
y/y
0.1
y/y
-0.2
y/y
0.1-0.111.6
y/y
2.2
y/y
3.1Evidence

Revenue & EBITDA

RevenueEBITDA

Quarterly values ($ mln)

01 0002 0003 0002024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q12026 q2

Year-over-year change

-200%0%200%400%2024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q12026 q2

Cash flow

FCF ($ mln)

02004006002024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q12026 q2

Net debt / cash ($ mln)

01 0002 0003 0002024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q12026 q2

Profit and cash

Profit is cash-backed
In a typical year of 2021–2025 operating cash flow came to 3.20x of reported net profit; after capex, 2.10x. Loss years (2022, 2023) are left out of the ratio.
year20212022202320242025
cash flow / profit8.97x2.92x3.20x
accruals, % of assets-6.2%-8.7%-10.1%-11.3%-10.6%
Last twelve months (to 2026-06-30): 3.65x of profit came back as operating cash flow.
net debt / EBITDA 1.4x · capex 2.5x of depreciation
Read from the reported annual statements: cash flow / profit is the median of the yearly operating cash flow over net profit for the years shown; accruals are (profit − operating cash flow) / assets, the classic gap between what was booked and what was collected. A gap can be growth in working capital, capitalised costs, revaluations or profit from associates — the panel points at it, the statements explain it. Not investment advice.

Research & reviews

Our earnings breakdowns and investment notes on this issuer.

All research →

Key-commodity price — Chicken

Current 2spot vs LTM -2%

Commodity-player potential

Potential withheld: no reliable market quote (market cap and multiples unavailable).

Spot model vs reported — the spot model's projection (trailing-LTM base brought to the period × the period's commodity-price move) vs the actual report, per reported period; USD mln. green = reported above projection, pink = below.

PeriodAct. revModel revΔ revAct. EBITDAModel EBITDAΔ EBITDA
2023 Q32 7362 706+1.1%246253-2.7%
2023 Q43 1172 695+15.7%383184+108.1%
2024 Q12 6142 781-6.0%410292+40.7%
2024 Q22 6612 812-5.4%458349+31.3%
2024 Q32 6942 828-4.7%499472+5.8%
2024 Q41 9662 793-29.6%311468-33.5%
2025 Q12 7602 530+9.1%484421+15.2%
2025 Q22 7562 550+8.1%442433+2.0%
2025 Q33 0472 589+17.7%466471-1.0%
2025 Q43 3162 666+24.4%472414+14.0%
2026 Q13 0552 979+2.5%466408+14.2%
2026 Q23 1443 004+4.7%488331+47.2%

Revenue growth & acceleration

Growth accelerating ▲
Last-year revenue growth +20% vs -10% the year before — a +29.9 pp move. 3-year CAGR +4%.
revenue growth by year: 2023 +6% · 2024 -10% · 2025 +20%
The growth-acceleration signal behind the GARP+acceleration strategy — it favours companies whose revenue growth is speeding up and flags those slowing down (the second derivative of growth).

EV/EBITDA — LTM vs projected

Projected EV/EBITDA 4.1x · target 75th pct (3y) 5.6x · LTM avg 4.0x

EV/EBITDA (LTM)EV/EBITDA (projected)target 75th pct (projected, 3y)

Dividends

No dividend rows found for this issuer (checked: Yahoo Finance (ex-div)).

Reporting forms detected in loaded periods: (Balance sheet / Profit or loss (P&L) / Cash flows)

Financial results, valuation multiples (P/E, P/B, EV/EBITDA), profitability and dividend yield of BRF S.A. (BRFS) — from primary filings.

Frequently asked questions

What is BRF S.A. (BRFS)'s P/E ratio?
BRF S.A. (BRFS) trades at a P/E of 5.8x (price to trailing 12-month earnings).
What is BRF S.A. (BRFS)'s EV/EBITDA?
BRF S.A. (BRFS) trades at 3.0x EV/EBITDA.
What is BRF S.A. (BRFS)'s P/B ratio?
BRF S.A. (BRFS) trades at a P/B of 1.0x.
What is BRF S.A. (BRFS)'s return on equity (ROE)?
BRF S.A. (BRFS)'s ROE is 14.1%.
What is BRF S.A. (BRFS)'s market capitalization?
BRF S.A. (BRFS)'s market cap is 2.7 bn USD.

See also: The Cheapest Stocks in the World (2026): What Value Investing Says About Buying Cheap · global valuation map